USPTO serial 88777540
NEOSMART
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAYES, LAURIE ANN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEOSMART?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anessa O. Kramer
Anessa O. Kramer Honigman LLP39400 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304-5151UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for medical testing and analysis of medical test results; downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; downloadable software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; downloadable software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis; downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human and human medical conditions; downloadable software for medical testing and analysis of medical test results; downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis | ACTIVE | — |
| 041 | Educational services, namely, providing on-line training courses and seminars in the fields of scientific testing and research services, human disease, human medical conditions, medical diagnostic testing services, medical research services, clinical scientific testing, and medical testing; educational services, namely, conducting in-person and online seminars, webinars, lectures, presentations, classes and workshops in the field of oncology, medical testing, and diagnostic testing; providing online, non-downloadable reports for others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing an interactive website featuring online, non-downloadable reports in the field of scientific research in pathology, diagnostic testing, oncology testing | ACTIVE | — |
| 042 | Providing on-line non-downloadable software for processing images, graphics and text; providing on-line non-downloadable software for medical testing and analysis of medical test results; providing on-line non-downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; providing on-line non-downloadable software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; providing on-line non-downloadable software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis; software as a service (SAAS) services for software for processing images, graphics and text; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical scientific research, namely, study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis for scientific purposes, and for clinical study and testing of cells for scientific purposes; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing medical research and scientific research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, and for clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing for scientific purposes, molecular sequencing for scientific purposes, cancer study and analysis for scientific and research purposes, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; providing on-line non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; genetic testing, RNA testing and sequencing for scientific purposes; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for medical research purposes in the field of human disease and human medical conditions; medical laboratory services, namely, clinical laboratory services, and oncology reference laboratory services, providing medical research and scientific research information to others in the field of pathology, diagnostic testing, oncology testing; providing an interactive website featuring medical research information in the field of scientific research in pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; medical laboratory services, namely, medical oncology reference laboratory services; providing cloud-based medical information in the nature of providing temporary use of non-downloadable cloud based software for providing information in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes | ACTIVE | — |
| 044 | Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and in the field of medical information relating to scientific and medical test results | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NeoGenomics Laboratories, Inc.
- Other trademarks owned by NeoGenomics Laboratories, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEOSMART
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 13, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 23, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 15, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 14, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 6, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 6, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 6, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 6, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 6, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 20, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 15, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 6, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2020 | ALIE | ASSIGNED TO LIE | — |
| Oct 14, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 14, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 14, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 14, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2020 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 26, 2020 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 26, 2020 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 3, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 3, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 1, 2020 | NWAP | NEW APPLICATION ENTERED | — |